Neurology Devices Market Report 2026

Neurology Devices Market Overview

• Neurology Devices market size has reached to $20.09 billion in 2025 • Expected to grow to $35.94 billion in 2030 at a compound annual growth rate (CAGR) of 12.5% • Growth Driver: Elevating Neurology Device Market Growth Through Favorable Government Initiatives • Market Trend: Advancements in Implantable Wireless Brain Devices Revolutionizing Neurology Treatment: Medtronic's Launch of NeuroSmart MER System for Enhanced DBS Procedures • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neurology Devices Market?

Neurology devices are used to diagnose, prevent, and treat various neurological disorders such as Alzheimer’s, spinal cord injury, and traumatic brain injury. These devices are also used to restore hearing and sight for patients with limb loss or congenital limb differences. The main types of neurology devices are cerebrospinal fluid management (CSF) devices and equipment, interventional neurology devices and equipment, neurosurgery devices and equipment, and neurostimulation devices. The neurostimulation device is a device that generates the electrical impulses placed under the skin of specific parts of the patient's body. The type of expenditures is public and private. The products included are instruments/equipment and disposables. The various end-users involved are hospitals and clinics, diagnostic laboratories, and others.

What Is The Neurology Devices Market Growth Forecast?

The neurology devices market size is expected to see rapid growth in the next few years. It will grow to $35.94 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing investments in brain-computer interface research, rising adoption of precision neurology approaches, expansion of outpatient neurology treatment centers, growing demand for non-invasive neurodiagnostic tools, increasing focus on remote neurological monitoring. Major trends in the forecast period include increasing adoption of neurostimulation therapies, rising use of image-guided neurosurgical systems, growing integration of ai in neurological diagnostics, expansion of minimally invasive neurology procedures, enhanced focus on personalized neurological treatments.

Global Neurology Devices Market Segmentation

1) By Type: Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices 2) By Type of Expenditure: Public, Private 3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users Subsegments: 1) By Cerebrospinal Fluid Management (CSF) Devices And Equipment: CSF Shunts, CSF Drainage Systems, Ventriculostomy Devices 2) By Interventional Neurology Devices And Equipment: Intracranial Stents, Embolic Coils, Neurovascular Catheters 3) By Neurosurgery Devices And Equipment: Surgical Microscopes, Surgical Navigation Systems, Neurosurgical Instruments 4) By Neurostimulation Devices: Deep Brain Stimulation Devices, Spinal Cord Stimulation Devices, Transcranial Magnetic Stimulation Devices

What Is The Driver Of The Neurology Devices Market?

Favorable government initiatives are expected to propel the growth of the neurology device market in the coming years. Government initiatives for medical devices encompass policies, regulations, and programs aimed at ensuring the safety, quality, and innovation of healthcare products. These initiatives can stimulate market growth by influencing regulations, funding research and development, offering financial incentives, expanding telemedicine, promoting public health awareness, and improving overall healthcare access. For instance, in October 2023, the Food and Drug Administration, a US-based federal agency under the Department of Health and Human Services, extended the Total Product Life Cycle Advisory Programme (TAP) to include neurological and physical medicine devices, aiming to accelerate technological advancements in these areas. By the first quarter of 2025, the FDA plans to add four more offices to the program and enroll up to 65 additional devices. Therefore, favorable government initiatives are driving the growth of the neurology device industry.

Key Players In The Global Neurology Devices Market

Major companies operating in the neurology devices market are Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Integra LifeSciences, Abbott Laboratories, LivaNova PLC, Integer, Penumbra Inc., B. Braun Group, Johnson & Johnson, W.L Gore, St. Jude Medical LLC, Parasym, Smiths Medical, Cizeta Surgical, Neuro France Implants, Ectron, Accentus Medical Ltd, Argonaut Therapeutics, Brainwave Discovery, Cerus Endovascular, Chronus Therapeutics, Natus Medical Incorporated, Cerenovus, Nevro, Aleva Neurotherapeutics SA, Cyberonics Inc.

Global Neurology Devices Market Trends and Insights

Major companies operating in the neurology devices market are focused on developing Advancements in Implantable Wireless Brain Devices Transforming Neurology Treatment, such as advanced medical devices to enhance treatment for neurological disorders through real-time monitoring and brain-computer interfaces. These innovations focus on minimally invasive techniques, improved patient outcomes, and personalized therapies. An advanced medical device is a sophisticated instrument that uses cutting-edge technology for diagnostic, therapeutic, or monitoring purposes. For instance, in April 2024, Medtronic, an Ireland-based medical device company, launched a NeuroSmart Portable Micro Electrode Recording (MER) Navigation System that enhances Deep Brain Stimulation (DBS) procedures for Parkinson's disease by providing real-time, precise electrode placement and automatic navigation, leading to improved patient outcomes and reduced side effects. Its portability and advanced technology empower clinicians to deliver tailored treatments effectively.

What Are Latest Mergers And Acquisitions In The Neurology Devices Market?

In November 2024, Nihon Kohden, a Japan-based provider of high-precision patient monitoring systems and neurological diagnostics equipment, acquired a 71.4% stake in NeuroAdvanced Corp. for an undisclosed amount. Through this acquisition, Nihon Kohden aims to enhance its presence in the neurology devices market by integrating its established EEG system expertise with Ad-Tech’s specialized intracranial electrodes, thereby expanding its capabilities in comprehensive epilepsy diagnostics and neurological care. NeuroAdvanced Corp. is a US-based manufacturer of specialized electrodes for long-term EEG monitoring, brain mapping, SEEG, and brain stimulation.

Regional Outlook

North America was the largest region in the global neurology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Neurology Devices Market?

The neurology devices market consists of sales of neuro thrombectomy devices, carotid artery stents, embolic coils, and support devices that are used to treat neurological disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.